The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB.
 
Hiroji Uemura
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Janssen
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kissei Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Pharma (Inst)
 
Kazuki Kobayashi
(OPTIONAL) Uncompensated Relationships - Astellas Pharma (Inst)
 
Akira Yokomizo
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Sanofi
Consulting or Advisory Role - Bayer; Janssen
Travel, Accommodations, Expenses - Sanofi
 
Shiro Hinotsu
Consulting or Advisory Role - Astellas Pharma
 
Shigeo Horie
Honoraria - Astellas Pharma; Bayer; Kissei Pharmaceutical; Kyorin; Nihonkayaku; Nippon Shinyaku; Pfizer; Sanofi
Consulting or Advisory Role - Angfa; Astellas Pharma
 
Yoshiyuki Kakehi
Consulting or Advisory Role - Astellas Pharma
 
Seiji Naito
Consulting or Advisory Role - Astellas Pharma
 
Norio Nonomura
Honoraria - Astellas Pharma; AstraZeneca; Asuka Seiyaku; Bayer; Bristol-Myers Squibb; Chugai Pharma; Eisai; Janssen; Kissei Pharmaceutical; Kyorin; MSD; Nippon Shinyaku; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Asuka Seiyaku (Inst); Chugai Pharma (Inst); Daiichi-Sankyo (Inst); Kissei Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); MSD (Inst); Nippon Kayaku (Inst); Nippon Shinyaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Teijin Pharma (Inst)
 
Osamu Ogawa
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma (Inst)
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Bayer
Research Funding - Astellas Pharma
 
Kazuhiro Suzuki
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma
 
Atsushi Saito
Employment - Astellas Pharma
 
Satoshi Uno
Employment - Astellas Pharma
 
Hideyuki Akaza
Consulting or Advisory Role - Astellas Pharma; Myovant Sciences; Taiho Pharmaceutical
Speakers' Bureau - Myovant Sciences; Pfizer
Research Funding - Astellas Pharma (Inst); Nippon Kayaku (Inst); Takeda (Inst); Yakult Honsha (Inst)